Other than the technical analysis that is shown in the chart, the fundamentals of this stock is screaming for a correction. The FTC will continue to affect $SPLS in a bearish manner as they continue to reject the acquisition between $SPLS and $ODP. This retest that Staples has been experiencing in the last month will fail after they will not meet the expectations...
Despite reporting 4Q losses, Agenus Inc. (or the company) showed an increase in share price. This shocked many analysts and some concluded that this was due to the earnings report exceeding revenue. But now the "Earnings Hype" is over for revenue does not do anything to the EPS if the company cannot clear its margins and produce profit. This will lead to a...
There's a lot take in on this chart. Clearly the stock is higher than it has ever been in the last six months. The reason for that is that the FDA has approved the drug that the company is working on to move on to the next phase. That sounds great but then how come it didn't move back to where it was six months ago? Well because that it did not go back to its past...
